PDCD1 and neoplasm: At this time, the exogenous selective inhibitor of PD-1, which should have been combined with PD-1 on T cell, would block tumour cell-derived PD-1 and thus free up tumour cell-derived PD-L1 to bind T-cell-derived PD-1.